Iambic Therapeutics, Inc. ($IAM)
Filing Information
| Accession Number | 0002151678-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 19, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
4,573,254
Total Value
$11,500,000.00
P&L
+2.1% (+$244,375.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 16, 2026 | Conversion | 1,458,736 | โ | โ | 1,458,736 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Oct 16, 2026 | Conversion | 410,762 | โ | โ | 1,869,498 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Oct 16, 2026 | Purchase | 718,750 | $16.00 | $11,500,000.00 | 2,588,248 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Oct 16, 2026 | Conversion | 57,754 | โ | โ | 57,754 | Indirect | See footnote | View Details | |
Director | Series B Convertible Preferred Stock | Derivative | Oct 16, 2026 | Conversion | 1,152,025 | $0.00 | $0.00 | 0 | Indirect | See footnote | View Details | |
Director | Series B Convertible Preferred Stock | Derivative | Oct 16, 2026 | Conversion | 57,754 | $0.00 | $0.00 | 0 | Indirect | See footnote | View Details | |
Director | Series B-3 Convertible Preferred Stock | Derivative | Oct 16, 2026 | Conversion | 306,711 | $0.00 | $0.00 | 0 | Indirect | See footnote | View Details | |
Director | Convertible Promissory Notes | Derivative | Oct 16, 2026 | Conversion | 410,762 | $0.00 | $0.00 | 0 | Indirect | See footnote | View Details |